Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.

Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.

Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

The first main kind is Soft Bag LVP, it hold a comparatively larger share in global market, which accounts for about 61.37% in 2018.
Another main kind is Glass Bottle LVP, for many companies, Glass Bottle LVP is attractive because of the market consumption need in the future. The Glass Bottle LVP share the rest 22.34% market share in 2018.
Plastic Bottle LVP hold the rest share, which accounts for about 16.29% in 2018.From the view of region, Asia-Pacific have a larger market share in 2018 which account for 46.29%, and will witness a stable growth in following years. North America and Europe hold a market share of 25.63% and 23.99% will still play an important role which cannot be ignored. Any changes from North America and Europe might affect the development trend of Large Volume Parenteral (LVP). South America and Middle East & Africa also play important roles in global market, but it will witness the comparatively low market share within selected regions.
The global Large Volume Parenteral (LVP) market is valued at 9759.8 million US$ in 2018 and will reach 17690 million US$ by the end of 2025, growing at a CAGR of 8.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Large Volume Parenteral (LVP) market based on company, product type, end user and key regions.

This report studies the global market size of Large Volume Parenteral (LVP) in key regions like North America, Europe, China, Japan, Middle East&Africa and India, focuses on the consumption of Large Volume Parenteral (LVP) in these regions.
This research report categorizes the global Large Volume Parenteral (LVP) market by top players/brands, region, type and end user. This report also studies the global Large Volume Parenteral (LVP) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Aspen Holdings
Beximco Pharma
Cook Pharmica
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs

Large Volume Parenteral (LVP) market size by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP

In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.

Large Volume Parenteral (LVP) market size by Applications
Basic Infusion
Therapeutic Infusion
Nutritious Infusion

In Large Volume Parenteral (LVP) market, Therapeutic Infusion segment holds an important share in terms of application, and it is expected to reach a volume of 9596 (M Units) by 2024, at a CAGR of 1.26% during 2019 and 2024. It means that Large Volume Parenteral (LVP) will be promising in the Therapeutic Infusion field in the next couple of years.

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Large Volume Parenteral (LVP) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Large Volume Parenteral (LVP) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Large Volume Parenteral (LVP) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Large Volume Parenteral (LVP) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Large Volume Parenteral (LVP) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Large Volume Parenteral (LVP) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.